| Dr Anthony Disciullo, MD | |
|
725 Concord Ave, Ste 1200, Cambridge, MA 02138-1040 | |
| (617) 354-5452 | |
| (617) 497-7503 |
| Full Name | Dr Anthony Disciullo |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 56 Years |
| Location | 725 Concord Ave, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972573913 | NPI | - | NPPES |
| 2031086 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 37881 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Auburn Hospital | Cambridge, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mt Auburn Professional Services | 6103725031 | 256 |
News Archive
Older patients hospitalized for acute care or a critical illness are more likely to experience cognitive decline compared to older adults who are not hospitalized, according to a study in the February 24 issue of JAMA.
A study conducted by the team of Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, has led to the discovery of a new approach to treat aortic valve stenosis through the administration of a compound that prevents valve deterioration and can even reverse the progression of the disease.
People who live in areas with lower household incomes are much more likely to die because of their personal and household characteristics and their community surroundings, according to Steven H. Woolf, M.D., M.P.H., director of the VCU Center on Human Needs, professor in the Department of Family Medicine and lead author of the study.
Exposure to second-hand tobacco smoke - even before conception - appears to have a lingering impact that can later impair the brain development of a fetus, researchers at Duke Health report.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
› Verified 6 days ago
| Entity Name | Mt Auburn Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992750996 PECOS PAC ID: 6103725031 Enrollment ID: O20040527001374 |
News Archive
Older patients hospitalized for acute care or a critical illness are more likely to experience cognitive decline compared to older adults who are not hospitalized, according to a study in the February 24 issue of JAMA.
A study conducted by the team of Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, has led to the discovery of a new approach to treat aortic valve stenosis through the administration of a compound that prevents valve deterioration and can even reverse the progression of the disease.
People who live in areas with lower household incomes are much more likely to die because of their personal and household characteristics and their community surroundings, according to Steven H. Woolf, M.D., M.P.H., director of the VCU Center on Human Needs, professor in the Department of Family Medicine and lead author of the study.
Exposure to second-hand tobacco smoke - even before conception - appears to have a lingering impact that can later impair the brain development of a fetus, researchers at Duke Health report.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony Disciullo, MD 725 Concord Ave, Ste 1200, Cambridge, MA 02138-1040 Ph: (617) 354-5452 | Dr Anthony Disciullo, MD 725 Concord Ave, Ste 1200, Cambridge, MA 02138-1040 Ph: (617) 354-5452 |
News Archive
Older patients hospitalized for acute care or a critical illness are more likely to experience cognitive decline compared to older adults who are not hospitalized, according to a study in the February 24 issue of JAMA.
A study conducted by the team of Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, has led to the discovery of a new approach to treat aortic valve stenosis through the administration of a compound that prevents valve deterioration and can even reverse the progression of the disease.
People who live in areas with lower household incomes are much more likely to die because of their personal and household characteristics and their community surroundings, according to Steven H. Woolf, M.D., M.P.H., director of the VCU Center on Human Needs, professor in the Department of Family Medicine and lead author of the study.
Exposure to second-hand tobacco smoke - even before conception - appears to have a lingering impact that can later impair the brain development of a fetus, researchers at Duke Health report.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
› Verified 6 days ago
Kathleen Forest Harney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1600 | |
Dr. Arielle Caplin, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 | |
Latoya Shari Jackson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-498-1660 | |
Dr. Eman Elkadry, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 725 Concord Ave, Ste 3300, Cambridge, MA 02138 Phone: 617-354-5452 Fax: 617-497-7503 | |
Alexander Bruscke, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 725 Concord Ave Ste 3500, Cambridge, MA 02138 Phone: 617-354-5452 | |
Arthur G Spector, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-2800 | |
Dr. Jessica Leigh Verosko, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1493 Cambridge St, Cha - Ob/gyn - Cambridge Campus, Cambridge, MA 02139 Phone: 617-498-1660 |